Does carvedilol reduce death and cardiovascular hospitalization in patients with chronic heart failure receiving standard therapy?
Carvedilol reduces mortality and cardiovascular hospitalizations in patients with chronic heart failure already treated with digoxin, diuretics, and ACE inhibitors.
Carvedilol reduces the risk or death as well as the risk of hospitalization for cardiovascular causes in patients with heart failure who are receiving treatment with digoxin, diuretics, and an angiotensin-converting-enzyme inhibitor.
Packer et al. (Thu,) studied this question.